BOSTON, June 20 /PRNewswire/ -- Four attorneys from Mintz, Levin, Cohn,
Ferris, Glovsky and Popeo, P.C. will speak at the Biotechnology Industry
Organization's BIO 2001 International Biotechnology Convention & Exhibition,
which will be held June 24-27 at the San Diego Convention Center.  More than
12,000 biotech industry leaders and executives from around the world are
expected to gather, showcasing the latest advances in health care,
agriculture, industrial manufacturing and environmental management.
    On Monday, June 25, Linda A. Bentley will chair a session entitled,
"Website.com - Guidelines for Product Disclosure in Light of FDA, SEC and FTC
Regulations."  Bentley is Of Counsel in Mintz Levin's Boston office,
practicing in the Health Care Section.  Also speaking will be William T.
Whelan, a member in Mintz Levin's Business and Finance Section in Boston.
    Jeffrey Wiesen, a member in Mintz Levin's Boston office and Chairman of
the firm's Biotechnology Practice, will chair and speak at a session on
Tuesday on the subject of "Beyond Licensing - Models for Sharing Risk and
Reward."  And on Wednesday, Raymond S. Fersko, a member in Mintz Levin's New
York office, will speak as part of a panel on "Managing the Deal for Success:
Biotech to Biotech, Biotech to Pharma."
    BIO 2001 is the largest biotechnology exhibition of its kind.  The
conference will feature more than 200 symposia and presentations on the latest
scientific research and product developments; bioethics and other public
policy issues; business, regulatory and financial strategies; and the growing
number of partnerships between high-tech and biotech companies.
    Mintz Levin is a full-service, multidisciplinary law firm with
approximately 500 attorneys and senior professionals in Boston, Washington,
D.C., Reston, New York, and New Haven who serve a diverse national and
international clientele. The firm has extensive expertise in all traditional
practice areas as well as technology law, venture capital, intellectual
property, the Internet, mass media, telecommunications, patents and software
licensing. The firm represents clients in established and emerging industries
including communications, biotechnology, pharmaceutical, medical device,
health care, high technology, and e-commerce, as well as capital sources such
as underwriters and venture capital firms. One of the first law firms to
develop MDP (multidisciplinary practice) capabilities, Mintz Levin has
consulting affiliates to address its clients' financial, public affairs and
related consulting needs.

     CONTACT:  Nancy J. Sterling, APR
               (617) 348-1811

Link to this page: